Zhiping Wang
Impact in
- Urology top 0.5%
- Urinary Bladder and Prostate Research
- Cancer Research top 5%
Papers in
-
- Epigenetics and DNA Methylation 11
-
- Kidney Stones and Urolithiasis Treatments 17
- Ferroptosis and cancer prognosis 11
- Prostate Cancer Treatment and Research 10
- Co-authors
- Shicui Zhang (9 shared papers)Hanzhang Wang (35 shared papers)Guangfeng Wang (5 shared papers)Jing‐Song Ou (17 shared papers)Junqiang Tian (26 shared papers)Yuejun Tian (9 shared papers)Ronald Rodríguez (27 shared papers)Wan Du (7 shared papers)
- Journals
- PLoS ONE (10 papers)Frontiers in Oncology (7 papers)Medicine (6 papers)American Journal of Physiology-Endocrinology and Metabolism (5 papers)Asian Journal of Andrology (5 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zhiping Wang
309 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 153
- Urology 375
- Cancer Research 516
- Immunology 598
- Molecular Biology 1.5k
- Pulmonary and Respiratory Medicine 651
Countries citing papers authored by Zhiping Wang
This map shows the geographic impact of Zhiping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiping Wang more than expected).
Fields of papers citing papers by Zhiping Wang
This network shows the impact of papers produced by Zhiping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiping Wang. The network helps show where Zhiping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhiping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 335 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 206 | |
| 2 | 2016 | 178 | |
| 3 | Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. | 2001 | 125 |
| 4 | 2012 | 120 | |
| 5 | 2012 | 97 | |
| 6 | 2010 | 93 | |
| 7 | 2009 | 93 | |
| 8 | 2014 | 88 | |
| 9 | 2008 | 88 | |
| 10 | 2010 | 80 | |
| 11 | 2015 | 78 | |
| 12 | 2014 | 70 | |
| 13 | 2009 | 69 | |
| 14 | 2016 | 66 | |
| 15 | 2008 | 65 | |
| 16 | 2017 | 64 | |
| 17 | 2010 | 63 | |
| 18 | 2016 | 62 | |
| 19 | 2010 | 59 | |
| 20 | 2011 | 58 |
About Zhiping Wang
Zhiping Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Urology, having authored 335 papers that have together received 5.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (28 papers), Urinary Bladder and Prostate Research (24 papers), Kidney Stones and Urolithiasis Treatments (17 papers), Ferroptosis and cancer prognosis (11 papers), Epigenetics and DNA Methylation (11 papers), Prostate Cancer Treatment and Research (10 papers), Virus-based gene therapy research (10 papers) and Aquaculture disease management and microbiota (10 papers). The work is most often cited by research in Urology (375 citations), Cancer Research (516 citations), Immunology (598 citations), Molecular Biology (1.5k citations) and Pulmonary and Respiratory Medicine (651 citations). Zhiping Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shicui Zhang, Hanzhang Wang, Guangfeng Wang, Jing‐Song Ou, Junqiang Tian, Yuejun Tian, Ronald Rodríguez, Wan Du, Rui Xu and Zhilong Dong. Their work appears in journals such as PLoS ONE, Frontiers in Oncology, Medicine, American Journal of Physiology-Endocrinology and Metabolism and Asian Journal of Andrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.